Position in SEER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,956
-$5,978 QoQ
Shares Held
39,855
0.0% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. SEER ranks #246 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,956 | 39,855 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $72,934 | 39,855 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $86,485 | 39,855 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,289 | 39,855 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $69,121 | 40,900 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $94,479 | 40,900 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $80,573 | 40,900 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $68,712 | 40,900 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $113,202 | 59,580 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $66,229 | 34,139 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $2,491,151 | 1,127,218 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,947,277 | 1,158,613 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,701,495 | 1,218,004 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,555,659 | 1,302,700 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,579,163 | 1,496,016 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,757,607 | 3,548,336 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $62,042,451 | 4,071,027 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $102,938,359 | 4,512,861 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $191,814,909 | 5,555,022 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $185,942,189 | 5,672,428 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $272,193,934 | 5,441,702 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $298,498,344 | 5,317,035 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||